An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression / Schwarz, Lj; Hutchinson, Ke; Rexer, Bn; Estrada, Mv; Gonzalez Ericsson, Pi; Sanders, Me; Dugger, Tc; Formisano, L; Guerrero-Zotano, A; Red-Brewer, M; Young, Cd; Lantto, J; Pedersen, Mw; Kragh, M; Horak, Id; Arteaga, Cl.. - In: JOURNAL OF THE NATIONAL CANCER INSTITUTE. - ISSN 0027-8874. - (2017). [10.1093/jnci/djx065]

An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression.

Formisano L;
2017

2017
An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression / Schwarz, Lj; Hutchinson, Ke; Rexer, Bn; Estrada, Mv; Gonzalez Ericsson, Pi; Sanders, Me; Dugger, Tc; Formisano, L; Guerrero-Zotano, A; Red-Brewer, M; Young, Cd; Lantto, J; Pedersen, Mw; Kragh, M; Horak, Id; Arteaga, Cl.. - In: JOURNAL OF THE NATIONAL CANCER INSTITUTE. - ISSN 0027-8874. - (2017). [10.1093/jnci/djx065]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/698505
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 24
social impact